Viewbix Inc.

For the period ended Dec 31, 2025. Filed Mar 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 27, 2026

QXL$3.38-8.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Shareholders’ Equity

Common stock (*) · Additional paid-in · Accumulated · Total Attributed to the company’s · Non- Controlling · Total
Number · Amount · capital · Deficit · Shareholders · Interests · Equity
Balance as of January 1, 2025	5,296,945	3		28,482	(22,714)	5,771	1,736	7,507
Net loss	-	-		-	(19,285)	(19,285)	(1,530)	(20,815)
Share-based compensation (see note 15.A)	37,500	-(**	)	75	-	75	3	78
Shares issued in connection with the Reverse Stock Split (see note 15.E)	14	-(**	)	-	-	-	-	-
Issuance of shares in connection with acquisition of a subsidiary (see note 8.C)	1,323,000	-(**	)	5,159	-	5,159	-	5,159
Issuance of shares and warrants in connection with conversion of loans (see notes 11.D, 11.E, 11.F)	922,957	-(**	)	11,072	-	11,072	-	11,072
Issuance of shares and warrants in connection with a private placement (see note 15.C)	848,763	-(**	)	4,023	-	4,023		4,023
Exercise of warrants (see notes 15.A, 15.B, 15.C)	2,241,213	1		2,221	-	2,222	-	2,222
Redemption of loan to parent company (see note 17)	-	-		-	(4,048)	(4,048)	-	(4,048)
Deconsolidation of Cortex (see note 8.B)	-	-		-	-	-	(209)	(209)
Balance as of December 31, 2025	10,670,392	4		51,032	(46,047)	4,989	-	4,989

(*)	Share and per share data in these financial statements have been retrospectively adjusted, for all periods presented, to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 15.E).

(**)	Represents an amount less than $1.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

Common stock (*) · Additional paid-in · Accumulated · Total Attributed to the company’s · Non- Controlling · Total
Number · Amount · capital · Deficit · Shareholders · Interests · Equity
Balance as of January 1, 2024	3,732,169	3		25,476	(10,661)	14,818	3,806	18,624
Net loss	-	-		-	(12,053)	(12,053)	(2,053)	(14,106)
Share-based compensation (see note 15.F)	-	-		12	-	12	(1)	11
Expiration of options granted to subsidiary’s employees	-	-		16	-	16	(16)	-
Issuance of shares upon RSUs vesting (see note 15.F)	6,378	-(**	)	-	-	-	-	-
Issuance of shares to consultants (see note 15.A)	120,000	-(**	)	57	-	57	-	57
Issuance of shares and warrants in connection with short-term loan and convertible loans (see notes 11, 15.A)	1,168,679	-(**	)	890	-	890	-	890
Issuance of shares and warrants in connection with a private placement (see note 15.B)	269,719	-(**	)	198	-	198	-	198
Reclassification of derivative warrant liability to equity (see note 11.D)	-	-		1,833	-	1,833	-	1,833
Balance as of December 31, 2024	5,296,945	3		28,482	(22,714)	5,771	1,736	7,507

(*)	Share and per share data in these financial statements have been retrospectively adjusted, for all periods presented, to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 15.E).

(**)	Represents an amount less than $1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.